top of page

Poseida's soon-to-be CEO on this morning's allo BCMA CAR-T data at #ASH23

Kristin Yarema elaborates on Poseida's ASH data, describes how she believes that honing in on the right preconditioning regimen might be the success factor, and highlights next steps.

Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page